FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4294927754> ?p ?o ?g. }

• W4294927754 abstract "Objective: To systematically review the efficacy and safety of botanical drugs in the treatment of cancer-related fatigue (CRF) caused by gastric cancer (GC) and to determine the underlying pharmacological mechanisms using a network analysis. Methods: Databases such as China National Knowledge Infrastructure (CNKI), SinoMed, Wanfang, Pubmed, Embase, Cochrane Library, and Web of Science were searched for randomized controlled trials (RCTs) from inception to 18 April 2022. Methodological quality assessment was performed using the collaborative tool Cochrane, and data analysis were carried out using RevMan 5.4 and STATA 16 software. The botanical drugs with the highest frequency of use in the included studies was selected. The chemical composition, targets of action, disease targets, and shared targets of these botanical drugs were screened based on network analysis to explore the potential mechanisms of treating CRF in patients with gastric cancer (GC). Results: A total of 13 studies that included 986 patients with gastric CRF met the inclusion criteria. The results showed that botanical drugs could improve the CRF scores of gastric CRF, including the total scores of CRF dichotomous data [Odds Ratio (OR) = 4.22; 95% confidence interval (CI) 1.67–10.68; p = 0.002], the total scores of CRF continuous data [Standardized Mean Difference (SMD) = -0.98; 95% CI -1.36 to -0.60; p &lt; 0.00001], the affective subscales of Piper Fatigue Scale (PFS) scores [Weighted Mean Difference (MD) = -0.79; 95%CI -0.92 to -0.65; p &lt; 0.00001], the sensory subscales of PFS scores (MD = -0.57; 95%CI -0.77 to -0.37; p &lt; 0.00001), the behavioral subscales of PFS scores (MD = -1.05; 95% CI -1.29 to -0.82; p &lt; 0.00001), Quality of Life Questionnaire Core 30 (QLQ-C30) (MD = 10.53, 95% CI 8.26 to12.80; p &lt; 0.00001), and the Karnofsky Performance Status scale (KPS) (MD = 5.18, 95% CI 2.60 to 7.76; p &lt; 0.0001). The botanical drugs group had milder adverse effects than the control group. A total of 44 chemical components and 241 potential targets were obtained from the online database and 121 drug targets overlapped with the disease targets of CRF in patients with GC. Moreover, five key active ingredients, namely quercetin, Stigmasterol, luteolin, kaempferol, and isorhamnetin, as well as five key targets including AKT1, TP53, TNF, VEGFA, and CASP3, were screened. In addition, five key signaling pathways, including cancer, Hepatitis B, Prostate cancer, Hepatitis C, and Pancreatic cancer pathways, were obtained through enrichment analysis. Conclusion: The results of the study showed that botanical drugs have positive effects on CRF in patients with GC. However, more well-designed, multicenter, and large sample-sized Randomized Controlled Trials are required to evaluate the effectiveness of botanical drugs on CRF in patients with GC." @default.
• W4294927754 created "2022-09-08" @default.
• W4294927754 creator A5002563409 @default.
• W4294927754 creator A5005846435 @default.
• W4294927754 creator A5006078963 @default.
• W4294927754 creator A5007256199 @default.
• W4294927754 creator A5024546591 @default.
• W4294927754 creator A5026842391 @default.
• W4294927754 creator A5068031383 @default.
• W4294927754 creator A5084120665 @default.
• W4294927754 date "2022-09-07" @default.
• W4294927754 modified "2023-09-26" @default.
• W4294927754 title "Effects of botanical drugs in the treatment of cancer-related fatigue in patients with gastric cancer: A meta-analysis and prediction of potential pharmacological mechanisms" @default.
• W4294927754 cites W2001038217 @default.
• W4294927754 cites W2003239266 @default.
• W4294927754 cites W2023850801 @default.
• W4294927754 cites W2035060580 @default.
• W4294927754 cites W2046133119 @default.
• W4294927754 cites W2068008235 @default.
• W4294927754 cites W2073993866 @default.
• W4294927754 cites W2084731748 @default.
• W4294927754 cites W2111855180 @default.
• W4294927754 cites W2124679671 @default.
• W4294927754 cites W2140414061 @default.
• W4294927754 cites W2145639076 @default.
• W4294927754 cites W2162333871 @default.
• W4294927754 cites W2163352737 @default.
• W4294927754 cites W2167571044 @default.
• W4294927754 cites W2372637232 @default.
• W4294927754 cites W2583731638 @default.
• W4294927754 cites W2768581707 @default.
• W4294927754 cites W2888863394 @default.
• W4294927754 cites W2992857899 @default.
• W4294927754 cites W3119226392 @default.
• W4294927754 cites W3128646645 @default.
• W4294927754 cites W3149479473 @default.
• W4294927754 cites W3204974367 @default.
• W4294927754 cites W4200372354 @default.
• W4294927754 cites W4241051120 @default.
• W4294927754 cites W4281652770 @default.
• W4294927754 cites W4281684148 @default.
• W4294927754 doi "https://doi.org/10.3389/fphar.2022.979504" @default.
• W4294927754 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36160404" @default.
• W4294927754 hasPublicationYear "2022" @default.
• W4294927754 type Work @default.
• W4294927754 citedByCount "1" @default.
• W4294927754 countsByYear W42949277542023 @default.
• W4294927754 crossrefType "journal-article" @default.
• W4294927754 hasAuthorship W4294927754A5002563409 @default.
• W4294927754 hasAuthorship W4294927754A5005846435 @default.
• W4294927754 hasAuthorship W4294927754A5006078963 @default.
• W4294927754 hasAuthorship W4294927754A5007256199 @default.
• W4294927754 hasAuthorship W4294927754A5024546591 @default.
• W4294927754 hasAuthorship W4294927754A5026842391 @default.
• W4294927754 hasAuthorship W4294927754A5068031383 @default.
• W4294927754 hasAuthorship W4294927754A5084120665 @default.
• W4294927754 hasBestOaLocation W42949277541 @default.
• W4294927754 hasConcept C121608353 @default.
• W4294927754 hasConcept C126322002 @default.
• W4294927754 hasConcept C143998085 @default.
• W4294927754 hasConcept C156957248 @default.
• W4294927754 hasConcept C168563851 @default.
• W4294927754 hasConcept C2776478404 @default.
• W4294927754 hasConcept C3020774429 @default.
• W4294927754 hasConcept C44249647 @default.
• W4294927754 hasConcept C71924100 @default.
• W4294927754 hasConcept C95190672 @default.
• W4294927754 hasConceptScore W4294927754C121608353 @default.
• W4294927754 hasConceptScore W4294927754C126322002 @default.
• W4294927754 hasConceptScore W4294927754C143998085 @default.
• W4294927754 hasConceptScore W4294927754C156957248 @default.
• W4294927754 hasConceptScore W4294927754C168563851 @default.
• W4294927754 hasConceptScore W4294927754C2776478404 @default.
• W4294927754 hasConceptScore W4294927754C3020774429 @default.
• W4294927754 hasConceptScore W4294927754C44249647 @default.
• W4294927754 hasConceptScore W4294927754C71924100 @default.
• W4294927754 hasConceptScore W4294927754C95190672 @default.
• W4294927754 hasLocation W42949277541 @default.
• W4294927754 hasLocation W42949277542 @default.
• W4294927754 hasLocation W42949277543 @default.
• W4294927754 hasLocation W42949277544 @default.
• W4294927754 hasOpenAccess W4294927754 @default.
• W4294927754 hasPrimaryLocation W42949277541 @default.
• W4294927754 hasRelatedWork W2013181888 @default.
• W4294927754 hasRelatedWork W2047252483 @default.
• W4294927754 hasRelatedWork W2286371484 @default.
• W4294927754 hasRelatedWork W2790570163 @default.
• W4294927754 hasRelatedWork W2806018152 @default.
• W4294927754 hasRelatedWork W3092583346 @default.
• W4294927754 hasRelatedWork W3152374296 @default.
• W4294927754 hasRelatedWork W4207070666 @default.
• W4294927754 hasRelatedWork W4291824836 @default.
• W4294927754 hasRelatedWork W4317438754 @default.
• W4294927754 hasVolume "13" @default.
• W4294927754 isParatext "false" @default.
• W4294927754 isRetracted "false" @default.
• W4294927754 workType "article" @default.